Glycogen storage disease type II - PDFSEARCH.IO - Document Search Engine

Glycogen storage disease type II
Results: 169

#	Item
131	You are cordially invited to attend the 2nd Annual INFANTILE Pompe Patient Meeting Hosted by the Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2014-06-10 17:43:15 Hepatology Duke University Medical genetics Medicine Health Glycogen storage disease type II
132	BioMarin is currently seeking patients for a Phase 3 clinical trial in Late Onset Pompe Disease. This phase 3 study incorporates a switchover design in which all patients switch directly from Myozyme® or Lumizyme® 1to Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2014-06-16 18:19:57 Glycogen storage disease type II Hepatology BioMarin Pharmaceutical Sanofi Alglucosidase alfa Genzyme Clinical trial ClinicalTrials.gov Medicine Health Science
133	Dolencias extraordinarias, medidas extremas Add to Reading List Source URL: ec.europa.eu Language: English - Date: 2013-09-27 09:59:11 Epidemiology Lysosomal storage diseases Glycogen storage disease type II Hepatology Extraordinary Measures John Crowley William Canfield Adrenoleukodystrophy Clinical trial Health Medicine Rare diseases
134	PDF Document Add to Reading List Source URL: www.agsd.org.uk Language: English - Date: 2014-04-14 15:27:49 Lysosomal storage diseases Prevention Screening Glycogen storage disease type II Health Medicine Rare diseases
135	非売品糖原病 Ⅱ 型︵ポンペ病︶診断治療ガイドライン Glycogen Storage Disease Type II I Add to Reading List Source URL: www.pmdrinsho.jp Language: Japanese - Date: 2008-03-18 20:26:40
136	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use MYOZYME safely and effectively. See full prescribing information for MYOZYME. MYOZYME® (alglucosidase alfa) Injecta Add to Reading List Source URL: www.myozyme.com Language: English - Date: 2014-05-27 09:58:04 Glycogen storage disease type II Hepatology Alglucosidase alfa Infusion pump Lorazepam Medicine Health Organochlorides
137	United States Court of Appeals For the First Circuit No[removed]IN RE: GENZYME CORP. SECURITIES LITIGATION, Add to Reading List Source URL: www.courthousenews.com Language: English - Date: 2014-06-10 11:20:05 Pharmaceutical sciences Genzyme Sanofi Orphan drugs Glycogen storage disease type II Alglucosidase alfa Prescription Drug User Fee Act Imiglucerase Alpha-galactosidase Medicine Health Food and Drug Administration
138	Combating Rare Diseases in the 21st Century The Orphan Drug Act What is a Rare Disease? Add to Reading List Source URL: www.chi.org Language: English - Date: 2014-02-27 15:16:35 Lipid storage disorders Neurodegenerative disorders Drug discovery Epidemiology Orphan drug Orphan Drug Act Niemann–Pick disease Rare Disease Day Glycogen storage disease type II Health Medicine Rare diseases
139	We would like to take this opportunity to provide an important update to the Pompe Community Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2008-11-19 13:27:56 Alglucosidase alfa Glycogen storage disease type II Prescription Drug User Fee Act FDA Fast Track Development Program Genzyme William Canfield Medicine Health Food and Drug Administration
140	Microsoft PowerPoint - PompesRehab-Carter [Read-Only] Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2007-09-13 18:17:02 Rare diseases Lysosomal storage diseases Inborn errors of carbohydrate metabolism Muscular system Glycogen storage disease type II Hepatology Cardiomegaly Mitochondrial disease Duchenne muscular dystrophy Health Anatomy Medicine

UPDATE